Analyst Ratings for Horizon Pharma PLC (HZNP)

Updated: 2017-07-26

Analysts covering Horizon Pharma PLC (NASDAQ:HZNP) have given it a consensus rating of Buy. About 30 days ago, HZNP was issued an average rating of Buy.

11 analysts issued ratings on the stock, where 9 gave HZNP a buy rating, 0 issued an overweight rating, 2 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Investment analysts gave a few price targets for HZNP. The maximum price target given was 22, implying a possible profit of 66.41 percent. The most pessimistic price target was 10, implying potential capital losses of -24.36 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -76.76 percent. Meanwhile, fiscal year estimates have been revised upwards by 0 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -66.14 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts decreased their estimates.

HZNP has traded between a high of 23.44 and a low of 9.45 over the past year. Currently the stock is 39.89 percent higher than its low, and 43.6 percent lower than its 52-week high. HZNP has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HZNP value stock report compares HZNP to some of its peers using value stock charts. The stock has a market capitalization of $2.19 billion. HZNP's next earnings release will be on 0000-00-00, which is days away.